March 19, 2021
Big Data is our greatest potential weapon in the fight against cancer. Despite countless advancements, cancer remains the second-leading cause of death worldwide, and the burden on patients, families and society is profound.
Advanced diagnostics for cancer represent a major market opportunity for life sciences companies, according to the BCC Research report, Next-Generation Cancer Diagnostics: Technologies and Global Markets.
Three pressing needs in cancer diagnostics loom large: The first is earlier stage identification, identifying cancer before it has spread to other parts of the body. The second is a more accurate classification of suspicious lesions or nodules. Thirdly, we need cancer diagnostics that guide therapy decisions.
Explore the full report here: https://www.bccresearch.com/market-research/biotechnology/next-generation-cancer-diagnostics-technologies-report.html
Next Generation Cancer Diagnostics: Technologies and Global Markets( BIO081C )
Publish Date: Aug 2020
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email firstname.lastname@example.org or visit www.bccresearch.com/media to request access to our library of market research.